153 related articles for article (PubMed ID: 32463435)
41. Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec.
De Wals P; Lefebvre B; Deceuninck G; Longtin J
Vaccine; 2018 Jan; 36(3):421-426. PubMed ID: 29224962
[TBL] [Abstract][Full Text] [Related]
42. Epidemiology of invasive pneumococcal and Haemophilus influenzae diseases in Northwestern Ontario, Canada, 2010-2015.
Eton V; Schroeter A; Kelly L; Kirlew M; Tsang RSW; Ulanova M
Int J Infect Dis; 2017 Dec; 65():27-33. PubMed ID: 28951105
[TBL] [Abstract][Full Text] [Related]
43. Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children.
van der Linden M; Weiß S; Falkenhorst G; Siedler A; Imöhl M; von Kries R
Vaccine; 2012 Aug; 30(40):5880-5. PubMed ID: 22771186
[TBL] [Abstract][Full Text] [Related]
44. A surveillance system of Invasive Pneumococcal Disease in North-Eastern Italy.
Baldovin T; Lazzari R; Russo F; Bertoncello C; Buja A; Furlan P; Cocchio S; Palù G; Baldo V
Ann Ig; 2016; 28(1):15-24. PubMed ID: 26980506
[TBL] [Abstract][Full Text] [Related]
45. Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Pandemic and Nonpandemic Influenza Periods.
Hernández S; Muñoz-Almagro C; Ciruela P; Soldevila N; Izquierdo C; Codina MG; Díaz A; Moraga-Llop F; García-García JJ; Domínguez Á
J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31189583
[TBL] [Abstract][Full Text] [Related]
46. Impact of vaccination on invasive pneumococcal disease in adults with focus on the immunosuppressed.
Sangil A; Xercavins M; Rodríguez-Carballeira M; Andrés M; Riera M; Espejo E; Pérez J; Garau J; Calbo E
J Infect; 2015 Oct; 71(4):422-7. PubMed ID: 26192199
[TBL] [Abstract][Full Text] [Related]
47. Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance.
; Mackenzie GA; Hill PC; Jeffries DJ; Ndiaye M; Sahito SM; Hossain I; Uchendu U; Ameh D; Adeyemi O; Pathirana J; Olatunji Y; Abatan B; Muhammad BS; Ahameefula E; Fombah AE; Adeshola B; Lobga BG; Saha D; Mackenzie R; Odutola A; Plumb ID; Akano A; Ebruke BE; Ideh RC; Kuti B; Githua P; Olutunde E; Ofordile O; Green E; Usuf E; Badji H; Ikumapayi UN; Manjang A; Salaudeen R; Nsekpong ED; Jarju S; Antonio M; Sambou S; Ceesay L; Lowe-Jallow Y; Fofana S; Jasseh M; Mulholland K; Knoll M; Levine OS; Howie SR; Adegbola RA; Greenwood BM; Corrah T
Lancet Infect Dis; 2021 Sep; 21(9):1293-1302. PubMed ID: 34280357
[TBL] [Abstract][Full Text] [Related]
48. Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine.
Hsu K; Pelton S; Karumuri S; Heisey-Grove D; Klein J;
Pediatr Infect Dis J; 2005 Jan; 24(1):17-23. PubMed ID: 15665705
[TBL] [Abstract][Full Text] [Related]
49. Antimicrobial susceptibility and clonality of Streptococcus pneumoniae isolates recovered from invasive disease cases during a period with changes in pneumococcal childhood vaccination, Norway, 2004-2016.
Siira L; Vestrheim DF; Winje BA; Caugant DA; Steens A
Vaccine; 2020 Jul; 38(34):5454-5463. PubMed ID: 32616324
[TBL] [Abstract][Full Text] [Related]
50. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.
Halasa NB; Shankar SM; Talbot TR; Arbogast PG; Mitchel EF; Wang WC; Schaffner W; Craig AS; Griffin MR
Clin Infect Dis; 2007 Jun; 44(11):1428-33. PubMed ID: 17479937
[TBL] [Abstract][Full Text] [Related]
51. Invasive pneumococcal disease and the potential for prevention by vaccination in the United Kingdom.
Parsons HK; Metcalf SC; Tomlin K; Read RC; Dockrell DH
J Infect; 2007 May; 54(5):435-8. PubMed ID: 17052760
[TBL] [Abstract][Full Text] [Related]
52. Impact of pneumococcal conjugate vaccine (PCV7 and PCV13) on pneumococcal invasive diseases in Italian children and insight into evolution of pneumococcal population structure.
Camilli R; D'Ambrosio F; Del Grosso M; Pimentel de Araujo F; Caporali MG; Del Manso M; Gherardi G; D'Ancona F; Pantosti A;
Vaccine; 2017 Aug; 35(35 Pt B):4587-4593. PubMed ID: 28716556
[TBL] [Abstract][Full Text] [Related]
53. Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997-2006.
Motlova J; Benes C; Kriz P
Epidemiol Infect; 2009 Apr; 137(4):562-9. PubMed ID: 18796171
[TBL] [Abstract][Full Text] [Related]
54. The changing epidemiology of invasive pneumococcal disease after PCV13 vaccination in a country with intermediate vaccination coverage.
Ciruela P; Izquierdo C; Broner S; Muñoz-Almagro C; Hernández S; Ardanuy C; Pallarés R; Domínguez A; Jané M;
Vaccine; 2018 Nov; 36(50):7744-7752. PubMed ID: 30473132
[TBL] [Abstract][Full Text] [Related]
55. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.
Hanna-Wakim R; Chehab H; Mahfouz I; Nassar F; Baroud M; Shehab M; Pimentel G; Wasfy M; House B; Araj G; Matar G; Dbaibo G;
Vaccine; 2012 Dec; 30 Suppl 6():G11-7. PubMed ID: 23228352
[TBL] [Abstract][Full Text] [Related]
56. Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012.
Demczuk WH; Martin I; Griffith A; Lefebvre B; McGeer A; Lovgren M; Tyrrell GJ; Desai S; Sherrard L; Adam H; Gilmour M; Zhanel GG; ;
Can J Microbiol; 2013 Dec; 59(12):778-88. PubMed ID: 24313450
[TBL] [Abstract][Full Text] [Related]
57. Changes in the Nature and Severity of Invasive Pneumococcal Disease in Children Before and After the Seven-valent and Thirteen-valent Pneumococcal Conjugate Vaccine Programs in Calgary, Canada.
Ricketson LJ; Conradi NG; Vanderkooi OG; Kellner JD
Pediatr Infect Dis J; 2018 Jan; 37(1):22-27. PubMed ID: 28737622
[TBL] [Abstract][Full Text] [Related]
58. Invasive pneumococcal disease among HIV-positive individuals, 2000-2009.
Yin Z; Rice BD; Waight P; Miller E; George R; Brown AE; Smith RD; Slack M; Delpech VC
AIDS; 2012 Jan; 26(1):87-94. PubMed ID: 22008657
[TBL] [Abstract][Full Text] [Related]
59. Trends in serotypes and sequence types among cases of invasive pneumococcal disease in Scotland, 1999-2010.
Lamb KE; Flasche S; Diggle M; Inverarity D; Greenhalgh D; Jefferies JM; Smith A; Edwards GF; Denham B; McMenamin J; McDonald E; Mitchell TJ; Clarke SC; Robertson C
Vaccine; 2014 Jul; 32(34):4356-63. PubMed ID: 23806244
[TBL] [Abstract][Full Text] [Related]
60. Effect of the different 13-valent pneumococcal conjugate vaccination uptakes on the invasive pneumococcal disease in children: Analysis of a hospital-based and population-based surveillance study in Madrid, Spain, 2007-2015.
Picazo J; Ruiz-Contreras J; Casado-Flores J; Negreira S; Baquero F; Hernández-Sampelayo T; Otheo E; Méndez C;
PLoS One; 2017; 12(2):e0172222. PubMed ID: 28207888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
